Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions

James E. Cox, Steven M. Mccown, Jonathan M. Bridges, William Tyler

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Two experiments compared the potency of continuous infusions of cholecystokinin octapeptide (CCK-8) for reducing sucrose intake when administered into abdominal arteries or the jugular vein. Adult, male Sprague-Dawley rats received 22-min infusions of saline or several doses of CCK-8. Sucrose was available for 20 min, beginning 2 min after onset of infusions. In the first experiment, intraceliac CCK-8 in doses of 50, 125, and 312 ng produced significant reductions in intake, but no dose affected intake when administered into the jugular vein. In experiment 2, only the highest dose, 312 ng, suppressed intake when infused into the superior mesenteric artery, and jugular infusions were again ineffective. Behavioral observations indicated that intra-arterial CCK-8 had no affect on feeding within the first several minutes of test meals but accelerated the subsequent decline in incidence of feeding. These results suggest that receptors involved in cholecystokinin satiety are widely distributed within the gastrointestinal tract.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume270
Issue number2 39-2
StatePublished - 1996
Externally publishedYes

Fingerprint

Sincalide
Abdomen
Sucrose
Jugular Veins
Superior Mesenteric Artery
Cholecystokinin
Sprague Dawley Rats
Meals
Gastrointestinal Tract
Neck
Arteries
Inhibition (Psychology)
Incidence

Keywords

  • cholecystokinin octapeptide
  • gastrointestinal tract
  • rat
  • satiety

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions. / Cox, James E.; Mccown, Steven M.; Bridges, Jonathan M.; Tyler, William.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 270, No. 2 39-2, 1996.

Research output: Contribution to journalArticle

@article{f16aaa90f7154a8bbb60a39079e7423b,
title = "Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions",
abstract = "Two experiments compared the potency of continuous infusions of cholecystokinin octapeptide (CCK-8) for reducing sucrose intake when administered into abdominal arteries or the jugular vein. Adult, male Sprague-Dawley rats received 22-min infusions of saline or several doses of CCK-8. Sucrose was available for 20 min, beginning 2 min after onset of infusions. In the first experiment, intraceliac CCK-8 in doses of 50, 125, and 312 ng produced significant reductions in intake, but no dose affected intake when administered into the jugular vein. In experiment 2, only the highest dose, 312 ng, suppressed intake when infused into the superior mesenteric artery, and jugular infusions were again ineffective. Behavioral observations indicated that intra-arterial CCK-8 had no affect on feeding within the first several minutes of test meals but accelerated the subsequent decline in incidence of feeding. These results suggest that receptors involved in cholecystokinin satiety are widely distributed within the gastrointestinal tract.",
keywords = "cholecystokinin octapeptide, gastrointestinal tract, rat, satiety",
author = "Cox, {James E.} and Mccown, {Steven M.} and Bridges, {Jonathan M.} and William Tyler",
year = "1996",
language = "English (US)",
volume = "270",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "2 39-2",

}

TY - JOUR

T1 - Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions

AU - Cox, James E.

AU - Mccown, Steven M.

AU - Bridges, Jonathan M.

AU - Tyler, William

PY - 1996

Y1 - 1996

N2 - Two experiments compared the potency of continuous infusions of cholecystokinin octapeptide (CCK-8) for reducing sucrose intake when administered into abdominal arteries or the jugular vein. Adult, male Sprague-Dawley rats received 22-min infusions of saline or several doses of CCK-8. Sucrose was available for 20 min, beginning 2 min after onset of infusions. In the first experiment, intraceliac CCK-8 in doses of 50, 125, and 312 ng produced significant reductions in intake, but no dose affected intake when administered into the jugular vein. In experiment 2, only the highest dose, 312 ng, suppressed intake when infused into the superior mesenteric artery, and jugular infusions were again ineffective. Behavioral observations indicated that intra-arterial CCK-8 had no affect on feeding within the first several minutes of test meals but accelerated the subsequent decline in incidence of feeding. These results suggest that receptors involved in cholecystokinin satiety are widely distributed within the gastrointestinal tract.

AB - Two experiments compared the potency of continuous infusions of cholecystokinin octapeptide (CCK-8) for reducing sucrose intake when administered into abdominal arteries or the jugular vein. Adult, male Sprague-Dawley rats received 22-min infusions of saline or several doses of CCK-8. Sucrose was available for 20 min, beginning 2 min after onset of infusions. In the first experiment, intraceliac CCK-8 in doses of 50, 125, and 312 ng produced significant reductions in intake, but no dose affected intake when administered into the jugular vein. In experiment 2, only the highest dose, 312 ng, suppressed intake when infused into the superior mesenteric artery, and jugular infusions were again ineffective. Behavioral observations indicated that intra-arterial CCK-8 had no affect on feeding within the first several minutes of test meals but accelerated the subsequent decline in incidence of feeding. These results suggest that receptors involved in cholecystokinin satiety are widely distributed within the gastrointestinal tract.

KW - cholecystokinin octapeptide

KW - gastrointestinal tract

KW - rat

KW - satiety

UR - http://www.scopus.com/inward/record.url?scp=0029878623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029878623&partnerID=8YFLogxK

M3 - Article

VL - 270

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 2 39-2

ER -